Science Committee

The Science Committee evaluates new scientific evidence about asthma care, and prepares updates to scientific reports on asthma management and prevention.

Macquarie University and University of Sydney
Sydney, NSW, Australia

Sydney Local Health District
Sydney, NSW, Australia

Professor of Pediatrics, Vanderbilt University Medical Center
Nashville, Tennessee, USA

Monroe Carell Jr Children’s Hospital
Nashville, Tennessee, USA

Department of Public Health and Infectious Diseases, Università Sapienza
Rome, Italy

National Heart and Lung Institute (NHLI), Imperial College
London, United Kingdom

University of Montpellier
Department of Respiratory Diseases
Montpellier, France

University of Leicester
Leicester, United Kingdom

Ghent University
Ghent, Belgium

Ghent University Hospital
Ghent, Belgium

Johannes Gutenberg University
Mainz, Germany

Senior Professor, Pulmonary Department
Johannes Gutenberg University Mainz, Germany

University of Montreal
Montreal, Canada

Centre Hospitalier Universitaire Sainte-Justine
Montreal, Canada

Erasmus MC, University Medical Center
Rotterdam, The Netherlands

Imperial College
London, United Kingdom

Imperial Healthcare NHS Trust and Royal Brompton Hospital
London, United Kingdom

Kagoshima University
Kagoshima, Japan

Kagoshima University Hospital
Kagoshima, Japan

University of Toronto
Toronto, Ontario, Canada

Family Physician Airways Group of Canada
Markham, Ontario, Canada

University of KwaZulu Natal
Durban, KwaZuluNatal

Inkosi Albert Luthuli Central Hospital
Durban, South Africa

Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA)
Porto Alegre, Brasil

Hospital Santa Casa de Porto Alegre
Porto Alegre, Brasil

Director Pulmocare Research and Education (PURE) Foundation
Pune, India

The Chinese University of Hong Kong
Hong Kong, China

Prince of Wales Hospital
Hong Kong, China

Shanghai Jiao Tong University School of Medicine
Shanghai, China

Department of Respiratory & Critical Care Medicine, Shanghai General Hospital
Shanghai, China

GINA Committee members disclose relationships (personal benefits, shares, and non-personal interests) with profit-making organizations in December of each year using the following definitions:

Non-Personal Interests refers to fees or grants paid to a GINA Committee member (or the Department/Institution on behalf of a GINA member) and used for research, education, equipment, salaries, etc.

Personal Benefits (Consultancy-Lecture Fees) refers to fees for lectures, advisory committees or consultancy services either intermittent or regular, from which a GINA member benefits personally. This includes ongoing attendance at advisory board meetings but would not normally include a situation where an individual is paid for a specific item or for attending or speaking at an occasional meeting.

Shares refers to any shares in the pharmaceutical industry, excluding unit trusts, pension plans or mutual funds, and it refers to shares held by a GINA member or family members (spouse/children). The company is to be listed, not the number of shares.


View Board and Committee Annual Disclosures